Sharad Goyal, MD, MS, is among 48 American Society for Radiation Oncology (ASTRO) members to receive the 2024 ASTRO Fellow (FASTRO) designation. Since its inception in 2006, the FASTRO designation has been awarded to just 498 of ASTRO’s 10,000 members worldwide. Goyal will be recognized at an awards ceremony on Oct. 1 in Washington, D.C., during ASTRO’s 66th Annual Meeting.
“Dr. Goyal, professor and division director of radiation oncology at the GW Cancer Center, joins an elite group of physicians and medical physicists who are recognized this year for their far-reaching contributions to the field of radiation oncology and their progress in advancing cancer research, education, and patient care,” said Jeff M. Michalski, MD, MBA, FASTRO, chair of the ASTRO Board of Directors. “Congratulations to Dr. Goyal for achieving the designation of ASTRO Fellow.”
Goyal is an internationally recognized radiation oncologist, researcher, and thought leader in breast cancer. His areas of research include improved treatment modalities and the identification of biomarkers in breast cancers. He is the author of more than 140 peer-reviewed publications (h-index 35) and serves on editorial boards and national committees related to imaging, health policy, and guidelines in oncology.
Goyal is a professor in the Department of Radiology, with a secondary appointment in the Department of Neurosurgery, at the George Washington University School of Medicine and Health Sciences. He received his BS (1998) and MD (2002) at the University of Virginia and completed his residency at Rutgers University. Goyal joined the GWU faculty in 2017 from Rutgers University, where he was an Associate Professor & Director of Research in the Department of Radiation Oncology.
Julie Bauman, MD, MPH, Dr. Cyrus Katzen Family Director of the GW Cancer Center, and associate dean of cancer at GW SMHS, said of Goyal’s accomplishment, “On behalf of the GW Cancer, congratulations to Dr. Goyal for earning this prestigious honor, recognizing him as a national leader in the field of radiation oncology.”
"I am incredibly honored to be named a Fellow of the American Society for Radiation Oncology," said Goyal. "Throughout my life, I have been incredibly fortunate to have wonderful mentors, and I owe this achievement to them. I am grateful for the recognition and support from ASTRO and would like to congratulate my esteemed colleagues who were also recognized with FASTRO designation."
